サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1464037

ADHD（注意欠如・多動症）治療薬の世界市場レポート 2024年

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ADHD（注意欠如・多動症）治療薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ADHD（注意欠如・多動症）治療薬市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.6％で164億2,000万米ドルに成長します。予測期間中の成長予測は、遺伝子研究と個別化医療の進歩、メンタルヘルス問題に対する意識の高まり、世界的・国家的メンタルヘルスプログラムの実施によってもたらされます。さらに、遠隔医療サービスの拡大や行動療法の導入も寄与しています。予測期間中に予想される主な動向には、治療方法における技術的ブレークスルー、進行中の研究開発努力、デジタル治療薬の統合、精密医療戦略の採用、ドラッグデリバリーシステムの進歩などがあります。

ADHD（注意欠如・多動症）の診断件数の増加傾向は、予測可能な将来においてADHD治療薬市場の拡大を促進すると予想されます。ADHD患者の急増は、この神経発達状態と闘う人口の増加を反映しています。ADHDの治療薬は、その多面的な症状に対処し、罹患者の症状コントロール、機能制限、生活の質、全体的な健康の向上に努めています。2023年1月現在、米国のGuardian紙の報道によると、2022年には17万人の患者がADHDの治療を受けており、2021年の14万1000人から20.4％も増加しています。したがって、ADHDの有病率の上昇は、ADHD治療薬市場の成長の主要な促進要因です。

ADHD治療薬分野の有力企業は、デジタルイノベーションに対する需要の高まりや遠隔ヘルスケアサービスに対するニーズの高まりに対応するため、ADHDの市販（OTC）デジタル治療薬Endeavorなどのデジタルソリューションの推進に注力しています。デジタル治療薬には、病状を予防、管理、治療するための洗練されたソフトウェアプログラムによる、エビデンスに基づく治療介入が含まれます。これらの介入は、単独での使用、または従来の医療治療との併用が意図されています。例えば、米国を拠点とするデジタルヘルス企業Akili社は、2023年6月、ADHDの成人向けに開発したビデオゲームをベースとするデジタル治療のOTC版を発表しました。EndeavorOTCと名付けられたこのソリューションは、注意力、時間管理能力、組織力を高めることを目的としています。さらに、この取り組みは、アキリが小児ADHD患者向けにFDAの承認を受けた処方箋ビデオゲーム療法EndeavorRxの成功に続くものです。このOTC製品は、成人のADHD患者に非薬理学的な選択肢を提供するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のADHD（注意欠如・多動症）治療薬市場：薬剤タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 精神刺激薬
  • 非精神刺激薬
  • 世界のADHD（注意欠如・多動症）治療薬市場：心理療法別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 行動療法
  • 認知行動療法
  • 対人関係心理療法
  • 家族療法
  • 世界のADHD（注意欠如・多動症）治療薬市場：年齢層別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 小児および青年
  • 成人
  • 世界のADHD（注意欠如・多動症）治療薬市場：流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院薬局
  • 専門クリニック
  • 小売薬局
  • eコマース

第7章 地域別・国別分析

  • 世界のADHD（注意欠如・多動症）治療薬市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のADHD（注意欠如・多動症）治療薬市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ADHD（注意欠如・多動症）治療薬市場：競合情勢
  • ADHD（注意欠如・多動症）治療薬市場：企業プロファイル
    • Pfizer Inc.
    • Johnson And Johnson Services Inc.
    • Novartis AG
    • GlaxoSmithKline plc
    • Takeda Pharmaceutical's

第31章 その他の大手企業と革新的企業

  • Eli Lilly and Company
  • Otsuka Pharmaceutical Co. Ltd.
  • UCB S.A.
  • Amneal Pharmaceuticals LLC
  • Lupin Ltd.
  • Mallinckrodt Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Purdue Pharma L.P.
  • Arbor Pharmaceuticals LLC
  • Tris Pharma Inc.
  • NEOS Therapeutic Inc.
  • Concert Pharmaceuticals Inc.
  • Vayarin AG
  • Rhodes Pharmaceuticals L.P.
  • KemPharm Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r16768

Attention deficit hyperactivity disorder (ADHD) therapeutics encompasses a spectrum of treatments and interventions designed to manage symptoms and enhance the functioning of individuals diagnosed with ADHD. ADHD is a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity, which significantly disrupt daily activities and development. The primary goal of ADHD therapeutics is to improve attention, impulse control, and overall functioning, thereby enhancing the quality of life for those affected by ADHD.

The main categories of drugs used in ADHD therapeutics are stimulants and non-stimulants. Stimulants are medications that elevate certain brain chemicals, thereby enhancing attention and focus. Additionally, various psychotherapies such as behavior therapy, cognitive behavioral therapy, interpersonal psychotherapy, and family therapy are utilized. These interventions are tailored for different age groups, including pediatric, adolescent, and adult populations, and are typically dispensed through hospital pharmacies, specialty clinics, retail pharmacies, and e-commerce platforms.

The attention deficit hyperactivity disorder (ADHD) therapeutics market research report is one of a series of new reports from The Business Research Company that provides attention deficit hyperactivity disorder (ADHD) therapeutics market statistics, including attention deficit hyperactivity disorder (ADHD) therapeutics industry global market size, regional shares, competitors with a attention deficit hyperactivity disorder (ADHD) therapeutics market share, detailed attention deficit hyperactivity disorder (ADHD) therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the attention deficit hyperactivity disorder (ADHD) therapeutics industry. This attention deficit hyperactivity disorder (ADHD) therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The attention deficit hyperactivity disorder (ADHD) therapeutics market size has grown strongly in recent years. It will grow from $12.37 billion in 2023 to $13.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed during the historical period can be credited to increased diagnostic awareness and screening initiatives, a rising prevalence of ADHD, advancements in treatment methods, expansion of healthcare infrastructure, and the broadening of health insurance coverage.

The attention deficit hyperactivity disorder (ADHD) therapeutics market size is expected to see strong growth in the next few years. It will grow to $16.42 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The projected growth during the forecast period is driven by advancements in genetic research and personalized medicine, rising awareness of mental health issues, and the implementation of global and national mental health programs. Additionally, the expansion of telehealth services and the incorporation of behavioral therapies are contributing factors. Key trends anticipated in the forecast period include technological breakthroughs in treatment methods, ongoing research and development efforts, the integration of digital therapeutics, the adoption of precision medicine strategies, and advancements in drug delivery systems.

The upward trend in attention-deficit hyperactivity disorder (ADHD) diagnoses is anticipated to drive the expansion of the ADHD therapeutics market in the foreseeable future. This surge in ADHD cases reflects a growing populace grappling with this neurodevelopmental condition. Therapies for ADHD address its multifaceted manifestations, striving to enhance symptom control, functional limitations, quality of life, and overall wellness among those affected. Notably, as of January 2023, reports from the Guardian, a US-based news outlet, indicate that around 170,000 identified patients were prescribed ADHD treatments in 2022, marking a 20.4% surge from the 141,000 patients noted during the corresponding period in 2021. Hence, the escalating prevalence of ADHD is a key driver of growth in the ADHD therapeutics market.

Prominent players in the ADHD therapeutics sector are concentrating on advancing digital solutions such as Endeavor over-the-counter (OTC) digital therapeutics for ADHD to cater to the escalating demand for digital innovations and the increasing need for remote healthcare services. Digital therapeutics entail evidence-based therapeutic interventions driven by sophisticated software programs to prevent, manage, or treat medical conditions. These interventions are intended for standalone use or in conjunction with conventional medical treatments. For instance, in June 2023, Akili, a US-based digital health firm, unveiled an over-the-counter (OTC) iteration of its video game-based digital therapy tailored for adults with ADHD. Branded as EndeavorOTC, this solution aims to enhance attention, time management, and organizational skills. Moreover, this initiative follows the success of Akili's FDA-approved prescription video game therapy, EndeavorRx, for pediatric ADHD patients. The OTC variant offers adults a non-pharmacological option for managing ADHD symptoms.

In March 2022, Optum Inc., a healthcare services provider based in the United States, completed the acquisition of Refresh Mental Health for $700 million. This strategic move aims to strengthen Optum's presence as a provider of outpatient mental and behavioral health services. The acquisition will enable Optum to broaden its offerings of effective behavioral care to patients and foster closer integration between medical and behavioral health services. Refresh Mental Health, a US-based company, specializes in providing a range of mental and behavioral health services, such as ADHD psychiatry and therapy.

Major companies operating in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Pfizer Inc., Johnson And Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical's, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., UCB S.A., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma L.P., Arbor Pharmaceuticals LLC, Tris Pharma Inc., NEOS Therapeutic Inc., Concert Pharmaceuticals Inc., Vayarin AG, Rhodes Pharmaceuticals L.P., KemPharm Inc., Impax Laboratories Inc., Aevi Genomic Medicine, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Highland Therapeutics Inc.

North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The attention deficit hyperactivity disorder (ADHD) therapeutic market consists of revenues earned by entities by providing services such as medication management, behavioral therapy, social skills training, and medication management. The market value includes the value of related goods sold by the service provider or included within the service offering. The attention deficit hyperactivity disorder (ADHD) therapeutic market also includes sales of medication, behavioral modification tools, organization and planning tools, and assistive technologies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on attention deficit hyperactivity disorder (ADHD) therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for attention deficit hyperactivity disorder (ADHD) therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The attention deficit hyperactivity disorder (ADHD) therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Type: Stimulants; Non-Stimulants
  • 2) By Psychotherapy: Behavior Therapy; Cognitive Behavioral Therapy; Interpersonal Psychotherapy; Family Therapy
  • 3) By Age Group: Pediatric And Adolescent; Adult
  • 4) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Retail Pharmacies; E-Commerce
  • Companies Mentioned: Pfizer Inc.; Johnson And Johnson Services Inc.; Novartis AG; GlaxoSmithKline plc; Takeda Pharmaceutical's
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Characteristics

3. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Trends And Strategies

4. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Growth

  • 5.1. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segmentation

  • 6.1. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Stimulants
  • Non-Stimulants
  • 6.2. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Psychotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Behavior Therapy
  • Cognitive Behavioral Therapy
  • Interpersonal Psychotherapy
  • Family Therapy
  • 6.3. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pediatric And Adolescent
  • Adult
  • 6.4. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Specialty Clinics
  • Retail Pharmacies
  • E-Commerce

7. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Regional And Country Analysis

  • 7.1. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 8.1. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 9.1. China Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 9.2. China Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 10.1. India Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 11.1. Japan Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 11.2. Japan Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 12.1. Australia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 13.1. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 14.1. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 14.2. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 15.1. Western Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 15.2. Western Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 16.1. UK Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 17.1. Germany Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 18.1. France Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 19.1. Italy Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 20.1. Spain Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 21.1. Eastern Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 21.2. Eastern Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 22.1. Russia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 23.1. North America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 23.2. North America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 24.1. USA Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 24.2. USA Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 25.1. Canada Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 25.2. Canada Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 26.1. South America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 26.2. South America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 27.1. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 28.1. Middle East Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 28.2. Middle East Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

  • 29.1. Africa Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview
  • 29.2. Africa Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Landscape
  • 30.2. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson And Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GlaxoSmithKline plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Takeda Pharmaceutical's
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Other Major And Innovative Companies

  • 31.1. Eli Lilly and Company
  • 31.2. Otsuka Pharmaceutical Co. Ltd.
  • 31.3. UCB S.A.
  • 31.4. Amneal Pharmaceuticals LLC
  • 31.5. Lupin Ltd.
  • 31.6. Mallinckrodt Pharmaceuticals Inc.
  • 31.7. Hisamitsu Pharmaceutical Co. Inc.
  • 31.8. Purdue Pharma L.P.
  • 31.9. Arbor Pharmaceuticals LLC
  • 31.10. Tris Pharma Inc.
  • 31.11. NEOS Therapeutic Inc.
  • 31.12. Concert Pharmaceuticals Inc.
  • 31.13. Vayarin AG
  • 31.14. Rhodes Pharmaceuticals L.P.
  • 31.15. KemPharm Inc.

32. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Benchmarking

33. Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market

35. Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Future Outlook and Potential Analysis

  • 35.1 Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer